Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 83 total PSOs listed by AHRQ.

CHART Institute LLC - P0078
Component of Parent Org(s):
  • Community Hospital Alternative for Risk Transfer (CHART RRG)
Effective Date and Time of Initial Listing: October 14, 2009 12:01 AM ET
Street Address: 2551 Washington Road Suite 810 Summerfield Commons, Upper St Clair, Pennsylvania 15241
PSO Phone Number: (412) 212-3338
Point of Contact: Kristen Rogers
Point of Contact Phone: 412-212-3338
Point of Contact Email: krogers@chartrrg.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 10/14/2019 through 10/13/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Carolinas Rehabilitation - Patient Safety Organization - P0094
Component of Parent Org(s):
  • Charlotte-Mecklenburg Hospital Authority
Effective Date and Time of Initial Listing: July 28, 2010 12:01 AM ET
Street Address: 1100 Blythe Blvd, Charlotte, North Carolina 28203
PSO Phone Number: 704-355-3777
Point of Contact: Danelle Higgins
Point of Contact Phone: 704-355-3704
Point of Contact Email: danelle.higgins@carolinas.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 07/28/2020 through 07/27/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes